Hedge Fund Database
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 26, 2026
The Invenomic Fund posted a net return of 14.38% net of fees for the third quarter of 2026, bringing year-to-date net performance to -5.65% through September 30, 2026. For the month of September, the fund fell -12.61% net of fees, underperforming the S&P 1500 Total Return Index return of -0.67% and the Morningstar Long/Short Equity category average of -1.24%. The fund operated with an average gross exposure of 203.3%, consisting of 111.1% long exposure and 92.2% short exposure, resulting in an average net equity exposure of 18.8% across 125 long holdings and 112 short positions. Underneath seemingly calm headline indices, market dynamics experienced severe factor dispersion and turbulence. The momentum factor delivered historically extreme performance, illustrated by a 27.0% monthly surge in the Goldman Sachs High Beta Momentum Basket, while the Russell 1000 Value/Growth Index dropped -5.3% and small-to-mid caps lagged mega caps. Invenomic observed that market participants are aggressively utilizing short equity positions as a funding mechanism to increase leverage in crowded artificial intelligence trades. Consequently, nearly 45% of S&P 500 components exhibited negative beta to the index, an extreme structural distortion unseen since the peak of the 2000 technology bubble. Invenomic remains positioned counter to market consensus by holding low- and negative-beta small- and mid-cap value longs while maintaining short positions against high-beta momentum leaders. While this positioning created sharp factor headwinds in September, management believes the market is approaching an inflection point that will trigger a broad rotation from crowded leaders into neglected laggards, continuing to trust its disciplined long/short process while preparing for continued near-term volatility.
The strategy seeks long-term capital appreciation by investing in low-beta, undervalued small- and mid-cap equities while shorting overextended, high-beta momentum stocks to capitalize on factor mean reversion.
Management anticipates an inflection point leading to a rotation of capital from momentum leaders into laggards, while expecting conditions to remain highly volatile throughout this transition.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Invenomic Capital Management or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.